Nang Kuang Partners with Chanelle to Commercialize Vardenafil Orodispersible Tablets in China and UK Markets
BEIJING Oct. 25，2023—-Nang Kuang has entered into a long-term exclusive distributing partnership with Chanelle Pharma (Chanelle) for the commercialization of Vardenafil Orodispersible 10mg Tablets for the treatment of erectile dysfunction.
Vardenafil 10 mg Orodispersible Tablets is indicated for the treatment of erectile dysfunction in adult men. Erectile dysfunction is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.
Chanelle Pharma is Ireland’s largest manufacturer of generic pharmaceuticals for human and animal health. Chanelle Pharma employs more than 700 people in Ireland, the UK, Portugal and Jordan. Headquartered in Loughrea Ireland, it has four manufacturing and five R&D facilities. Its global supply chain and distribution network exports to over 80 countries.
For more information, visit www.nangkuang-med.com